Skip to main content

Table 2 Laboratory investigations during 12 months of follow-up

From: Role of transient elastography in the prediction of de novo recurrence of hepatocellular carcinoma after radiofrequency ablation: single-center Egyptian study

  Base line 1 month 3 months 6 months 12 months F P
Mean SD Mean SD Mean SD Mean SD Mean SD
Serum albumin (g/dl) 3.88 0.39 3.68 .34 3.59 0.37 3.49 0.46 3.33 0.55 23.21 <0.001
Total bilirubin (mg/dl) 1.14 0.41 1.17 0.47 1.21 0.53 1.30 0.62 1.42 0.78 320.90 <0.001
INR 1.11 0.12 1.16 0.14 1.20 0.14 1.64 0.91 1.26 0.19 1.25 0.29
ALT (u/l) 43.37 14.18 47.87 14.55 44.23 20.73 45.10 20.08 44.23 20.73 1.52 0.20
AST (u/l) 53.73 18.41 56.43 17.87 56.43 17.87 51.87 11.14 52.80 10.65 1.76 0.14
TLC (103/mL) 5.53 2.36 5.17 2.14 5.04 1.92 5.18 2.18 4.84 1.92 1.71 0.15
HB (g/dl) 11.95 1.33 11.75 1.30 11.46 1.13 11.27 1.22 11.17 1.27 13.15 <0.001
Platelets (103/mL) 147830 51700 143830 47380 139730 50330 135800 49750 128730 50.00 7.72 <0.001
BUN (mg/dl) 16.07 6.93 16.83 7.29 17.87 7.61 15.63 5.77 18.73 7.39 1.68 0.16
CR (mg/dl) 0.92 0.19 0.97 0.20 0.99 0.24 1.00 0.26 1.08 0.33 4.004 0.004
NA (meq/l) 136.67 2.09 136.40 2.46 135.50 3.15 134.77 3.45 133.83 5.75 6.33 <0.001
k (meq/l) 4.11 .32 4.04 .31 3.85b .27 3.86 .35 3.77 0.44 8.75 <0.001
*AFP (ng/dl) 42.00 54.00 8.50 6.00 6.50 6.00 6.30 5.00 6.05 59.00 51.64 <0.001
  1. *Median and IQR